menu toggle
Thursday, November 26 - Friday, November 27
Cencora will be closed on Thursday, November 26 in observance of the Thanksgiving holiday. There will be no deliveries on this day and our Customer Service and Customer Systems Support teams will be unavailable. Our offices will also be closed on Friday, November 27. While deliveries for non-refrigerated product will be attempted on Friday, our offices will be closed. Customer Service may be limited and Customer System Support will also be limited and available by email only. Please review our full holiday schedule for more detailed information and to plan your orders accordingly.

October 6, 2026

Now available ZENBEXUS™

ZENBEXUS™ (iberdomide) capsules, for oral use, is a cereblon-modulating protein degrader indicated in combination with daratumumab and hyaluronidase-fihj and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least 1 prior line of therapy including a proteasome inhibitor and an immunomodulatory agent.
 
This indication is approved under accelerated approval based on minimal residual disease (MRD)-negative complete response (CR) at any time. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trial(s).


Please see full prescribing information here.


PLEASE NOTE: To access this ZENBEXUS product you must enroll and become certified in the ZENBEXUS REMS. 

For ZENBEXUS REMS information contact:
REMS Website: https://www.zenbexusrems.com
REMS Phone: 1.888.423.5436

We are NABP accredited